MedTrace Logo

Predictors and Outcomes of Dysglycemia in Pheochromocytoma and Paraganglioma

NCT05451134 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2022-07-12

No results posted yet for this study

Summary

The investigators will retrospectively analyze the clinical data of consecutive patients with pheochromocytomas and paragangliomas admitted between January 2018 and June 2020. The clinical characteristics of patients with and without dysglycemia will be compared, and whether surgery could improve the patients'dysglycemia will be also investigated.

Conditions

  • Pheochromocytoma
  • Paraganglioma

Interventions

OTHER

Catecholamines

Focus on whether catecholamine exposure is associated with dysglycemia in patients with pheochromocytoma and paraganglioma

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    collaborator OTHER

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Xian-Liang Zhou · National Center for Cardiovascular Diseases; Fuwai Hospital, Chinese Academy of Medical Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-30
Primary Completion
2022-07-20
Completion
2022-07-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05451134 on ClinicalTrials.gov